[Prediction for efficacy of endocrine therapy for breast cancers using gene profiling].
Department of Breast and Endocrine Surgery, Kumamoto University.
Hirotaka
H
Iwase
Yutaka
Y
Yamamoto
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000145:classification / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D005260:Female; D005544:Forecasting / Q000379:methods*; D020869:Gene Expression Profiling; D006801:Humans; D014411:Neoplastic Stem Cells; D011379:Prognosis; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D013629:Tamoxifen / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D013629:Tamoxifen